Cathelicidin LL-37 in Health and Diseases of the Oral Cavity

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 May 28

PMID 35625823

Authors

Joanna Tokajuk

Piotr Deptula

Ewelina Piktel

Tamara Daniluk

Sylwia Chmielewska

Tomasz Wollny

Przemyslaw Wolak

Krzysztof Fiedoruk

Robert Bucki

Affiliations

Soon will be listed here.

Abstract

The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome.

Citing Articles

Vitamin D and LL-37 in Serum and Saliva: Insights into Oral Immunity.

Davidopoulou S, Makedou K, Kourti A, Gkeka I, Karakostas P, Pikilidou M Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996823 PMC: 11854761. DOI: 10.3390/cimb47020102.

Natural Antimicrobial Peptides and Their Synthetic Analogues for Effective Oral Microflora Control and Oral Infection Treatment-The Role of Ceragenins in the Development of New Therapeutic Methods.

Czarnowski M, Wnorowska U, Luckiewicz M, Dargiewicz E, Spalek J, Okla S Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770567 PMC: 11678171. DOI: 10.3390/ph17121725.

Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris.

Lesiak A, Paprocka P, Wnorowska U, Mankowska A, Krol G, Gluszek K Front Immunol. 2025; 15():1502242.

PMID: 39744637 PMC: 11688235. DOI: 10.3389/fimmu.2024.1502242.

LL-37 regulates odontogenic differentiation of dental pulp stem cells in an inflammatory microenvironment.

Ma Y, Liu X, Dai R, Li Q, Cao C Stem Cell Res Ther. 2024; 15(1):469.

PMID: 39696668 PMC: 11656940. DOI: 10.1186/s13287-024-04075-7.

The Variability of the Salivary Antimicrobial Peptide Profile: Impact of Lifestyle.

Gallo M, Ferrari E, Giovati L, Pertinhez T, Artesani L, Conti S Int J Mol Sci. 2024; 25(21).

PMID: 39519054 PMC: 11547034. DOI: 10.3390/ijms252111501.

References

Wang G, Lakshmaiah Narayana J, Mishra B, Zhang Y, Wang F, Wang C . Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37. Adv Exp Med Biol. 2019; 1117:215-240. DOI: 10.1007/978-981-13-3588-4_12. View

Gorr S . Antimicrobial peptides in periodontal innate defense. Front Oral Biol. 2011; 15:84-98. PMC: 3704226. DOI: 10.1159/000329673. View

Radaic A, Kapila Y . The oralome and its dysbiosis: New insights into oral microbiome-host interactions. Comput Struct Biotechnol J. 2021; 19:1335-1360. PMC: 7960681. DOI: 10.1016/j.csbj.2021.02.010. View

Murakami M, Kameda K, Tsumoto H, Tsuda T, Masuda K, Utsunomiya R . TLN-58, an Additional hCAP18 Processing Form, Found in the Lesion Vesicle of Palmoplantar Pustulosis in the Skin. J Invest Dermatol. 2016; 137(2):322-331. DOI: 10.1016/j.jid.2016.07.044. View

Puklo M, Guentsch A, Hiemstra P, Eick S, Potempa J . Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol. 2008; 23(4):328-35. PMC: 2565510. DOI: 10.1111/j.1399-302X.2008.00433.x. View

Jonsson D, Nilsson B . The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in human periodontal ligament cells. J Periodontal Res. 2011; 47(3):330-5. DOI: 10.1111/j.1600-0765.2011.01436.x. View

Davidopoulou S, Diza E, Sakellari D, Menexes G, Kalfas S . Salivary concentration of free LL-37 in edentulism, chronic periodontitis and healthy periodontium. Arch Oral Biol. 2013; 58(8):930-4. DOI: 10.1016/j.archoralbio.2013.01.003. View

Sol A, Ginesin O, Chaushu S, Karra L, Coppenhagen-Glazer S, Ginsburg I . LL-37 opsonizes and inhibits biofilm formation of Aggregatibacter actinomycetemcomitans at subbactericidal concentrations. Infect Immun. 2013; 81(10):3577-85. PMC: 3811755. DOI: 10.1128/IAI.01288-12. View

Jagelaviciene E, Vaitkeviciene I, Silingaite D, Sinkunaite E, Daugelaite G . The Relationship between Vitamin D and Periodontal Pathology. Medicina (Kaunas). 2018; 54(3). PMC: 6122115. DOI: 10.3390/medicina54030045. View

10.

Tanaka D, Miyasaki K, Lehrer R . Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol Immunol. 2001; 15(4):226-31. DOI: 10.1034/j.1399-302x.2000.150403.x. View

11.

Jourdain M, Velard F, Pierrard L, Sergheraert J, Gangloff S, Braux J . Cationic antimicrobial peptides and periodontal physiopathology: A systematic review. J Periodontal Res. 2019; 54(6):589-600. DOI: 10.1111/jre.12676. View

12.

Turkoglu O, Emingil G, Eren G, Atmaca H, Kutukculer N, Atilla G . Gingival crevicular fluid and serum hCAP18/LL-37 levels in generalized aggressive periodontitis. Clin Oral Investig. 2016; 21(3):763-769. DOI: 10.1007/s00784-016-1834-z. View

13.

Zeth K, Sancho-Vaello E . Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures. Int J Mol Sci. 2021; 22(10). PMC: 8156758. DOI: 10.3390/ijms22105200. View

14.

Nilsson B . What can we learn about functional importance of human antimicrobial peptide LL-37 in the oral environment from severe congenital neutropenia (Kostmann disease)?. Peptides. 2020; 128:170311. DOI: 10.1016/j.peptides.2020.170311. View

15.

Darveau R, Belton C, Reife R, Lamont R . Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun. 1998; 66(4):1660-5. PMC: 108102. DOI: 10.1128/IAI.66.4.1660-1665.1998. View

16.

Nireeksha , Varma S, Damdoum M, Alsaegh M, Hegde M, Kumari S . Immunomodulatory Expression of Cathelicidins Peptides in Pulp Inflammation and Regeneration: An Update. Curr Issues Mol Biol. 2021; 43(1):116-126. PMC: 8929016. DOI: 10.3390/cimb43010010. View

17.

Wilhelm M, Schlegl J, Hahne H, Gholami A, Lieberenz M, Savitski M . Mass-spectrometry-based draft of the human proteome. Nature. 2014; 509(7502):582-7. DOI: 10.1038/nature13319. View

18.

Yu X, Quan J, Long W, Chen H, Wang R, Guo J . LL-37 inhibits LPS-induced inflammation and stimulates the osteogenic differentiation of BMSCs via P2X7 receptor and MAPK signaling pathway. Exp Cell Res. 2018; 372(2):178-187. DOI: 10.1016/j.yexcr.2018.09.024. View

19.

Ghosh S, Feng Z, Fujioka H, Lux R, McCormick T, Weinberg A . Conceptual Perspectives: Bacterial Antimicrobial Peptide Induction as a Novel Strategy for Symbiosis with the Human Host. Front Microbiol. 2018; 9:302. PMC: 5835341. DOI: 10.3389/fmicb.2018.00302. View

20.

Hayashi K, Iwata M . Stiffness of cancer cells measured with an AFM indentation method. J Mech Behav Biomed Mater. 2015; 49:105-11. DOI: 10.1016/j.jmbbm.2015.04.030. View